Clinical Trials Logo

Opiate Overdose clinical trials

View clinical trials related to Opiate Overdose.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT05645016 Suspended - Opioid Overdose Clinical Trials

Tailoring Overdose Education for Black Churches

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Church-based interventions are culturally acceptable, reduce access barriers, and can be brought to scale in under-resourced communities. For Overdose Education and Naloxone Distribution (OEND) to be efficacious in Black churches, tailoring may be needed. For this audience, standard OEND curricula may need to be adapted to their level of knowledge of substance use disorders (SUDs), and limited general mental health literacy, and specifically address stigma related to SUDs and medications for opioid use disorder (MOUD). Finally, a tailored implementation strategy may need to address contextual variations (e.g., denomination and membership size) across churches. The proposed pilot study aims to identify the socio-cultural modifications that will be needed to adapt our previously developed training (i.e., COEST) to target Black communities of faith. In a pilot randomized controlled trial (RTC) of adapted COEST in a stepped-wedge design.

NCT ID: NCT05114460 Suspended - Opioid Overdose Clinical Trials

Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal

Start date: November 1, 2021
Phase: Phase 2
Study type: Interventional

The goal of the proposed, proof-of-concept study is to test the combined effects of vaporized marijuana [Delta-9-tetrahydracannabinol (THC)] with NLX as a proof of concept towards the possible development of a combined overdose reversal agent with improved tolerability.